Prof. Faruk TAŞ

Oncology research and treatment , pp.1-7, 2024 (SCI-Expanded) Sustainable Development

Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer.

Postgraduate medicine , 2024 (SCI-Expanded) Sustainable Development

Comorbidity in Small Cell Lung Cancer: Prognostic Impacts of Hypertension/Coronary Artery Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease.

Cancer investigation , pp.1-13, 2024 (SCI-Expanded) Sustainable Development

Timing of chemotherapy after diagnosis of small cell lung cancer.

Journal of chemotherapy (Florence, Italy) , pp.1-6, 2024 (SCI-Expanded)

Effect of Histological Subtype on Metastasis Distribution in Resected Cutaneous Melanoma

INDIAN JOURNAL OF DERMATOLOGY , vol.69, no.1, pp.107, 2024 (SCI-Expanded)

Neither the presence nor the severity of hyponatremia affected the outcome of the patients with small cell lung cancer.

Irish journal of medical science , vol.192, no.4, pp.1613-1619, 2023 (SCI-Expanded) Sustainable Development

Median Age of Cutaneous Melanoma Presentation in Turkey from a Single Tertiary Center Is Younger Than Other Western Countries

TAŞ F., Erturk K.

INDIAN JOURNAL OF SURGERY , vol.85, no.4, pp.1010-1011, 2023 (SCI-Expanded)

Breast cancer patients are diagnosed at younger ages in Turkey: a comparative study.

Irish journal of medical science , vol.192, no.3, pp.1073-1075, 2023 (SCI-Expanded) Sustainable Development

Completion Lymph Node Dissection Is Unnecessary After Positive Sentinel Lymph Node in Melanoma — a Case Series Analysis

TAŞ F., Erturk K., Ferhatoglu F.

Indian Journal of Surgery , vol.85, no.3, pp.570-574, 2023 (SCI-Expanded) Sustainable Development

Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences

Ferhatoglu F., Erturk K., Taş F.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.19, no.(Suppl 1), pp.349-354, 2023 (SCI-Expanded)

Using Google as a Source of Information About Breast Cancer

INDIAN JOURNAL OF SURGERY , vol.85, no.2, pp.473-475, 2023 (SCI-Expanded) Sustainable Development

Turkey's contribution to cancer publication: Expected quantity, unsatisfactory quality.

Journal of cancer research and therapeutics , vol.19, no.Supplement, 2023 (SCI-Expanded)

Primary tumor SUV(max) and ratio of SUV(max) to primary tumor size on pretreatment 18F-FDG-PET/CT scan in small cell lung cancer : Which is superior for the prognosis?

Wiener klinische Wochenschrift , 2023 (SCI-Expanded) Sustainable Development

Online public interest in smoking and lung cancer: A comparative study in Google Trends.

Journal of cancer research and therapeutics , vol.19, no.Suppl 2, 2023 (SCI-Expanded) Sustainable Development

Diagnosing lung cancer at a younger age and with male dominance: Comparison of Turkish patients with United States patients.

Journal of cancer research and therapeutics , vol.19, no.Suppl 2, 2023 (SCI-Expanded) Sustainable Development

Melanoma publications do not increase as much as the incidence of melanoma in the last two decades.

Journal of cancer research and therapeutics , vol.19, no.Suppl 2, 2023 (SCI-Expanded)

Seasons Influence Diagnosis of Breast Cancer in Turkey

Taş F., Erturk K.

INDIAN JOURNAL OF SURGERY , vol.84, no.6, pp.1364-1365, 2022 (SCI-Expanded) Sustainable Development

Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival.

The American Journal of dermatopathology , vol.44, pp.799-805, 2022 (SCI-Expanded)

Successful Treatment of a 92-Year-Old Classic Kaposi's Sarcoma Man With Ultra-Low Dose Oral Etoposide.

Tas F., Sakar B.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.7, pp.1671-1673, 2022 (SCI-Expanded)

Larger Tumors Are Associated with Poorer Prognostic Factors in Cutaneous Melanoma

INDIAN JOURNAL OF SURGERY , vol.84, no.3, pp.591-594, 2022 (SCI-Expanded)

Unknown Primary Metastatic Melanoma Presented with Extensive Subcutaneous Masses and Lymph Node Enlargements

INDIAN JOURNAL OF SURGERY , vol.84, pp.579-580, 2022 (SCI-Expanded)

Digit melanomas are associated with poor prognostic factors and unfavorable survivals.

Journal of cosmetic dermatology , vol.21, pp.2120-2129, 2022 (SCI-Expanded)

Different mitotic rates are associated with different prognostic factors, relapses, and survival rates in melanoma.

International journal of dermatology , vol.61, no.4, pp.472-479, 2022 (SCI-Expanded)

Auricular and periauricular melanomas have similar clinicopathologic factors and survival rates.

Tas F., Erturk K., Ferhatoglu F.

Journal of cosmetic dermatology , vol.21, no.4, pp.1570-1573, 2022 (SCI-Expanded)

Complementary and alternative medicine (CAM) in Turkish cutaneous melanoma patients: A prospective study from tertiary cancer center.

Tas F., Cinar E., Erturk K.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.28, no.2, pp.282-286, 2022 (SCI-Expanded) Sustainable Development

Trunk melanomas: no survival differences between lesion sites.

Postgraduate medicine , vol.134, no.6, pp.609-615, 2022 (SCI-Expanded)

Limb melanomas: acral melanomas have worse survival.

The Journal of dermatological treatment , vol.33, no.3, pp.1630-1637, 2022 (SCI-Expanded)

Ulceration <i>vs</i> Mitosis in Cutaneous Melanoma: which is Superior for Predicting Prognosis Across Clinical Stages?

Cancer investigation , vol.40, pp.842-851, 2022 (SCI-Expanded)

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: retrospective real-life data.

Gürbüz M., Doğan İ., Akkuş E., Ermiş H., Utkan G., Taş F., et al.

Dermatologic therapy , vol.34, no.6, 2021 (SCI-Expanded)

Serum folate and vitamin B12 levels in cutaneous melanoma

Tas F., Erturk K., Soydinc H.

JOURNAL OF COSMETIC DERMATOLOGY , vol.20, no.9, pp.3007-3010, 2021 (SCI-Expanded)

Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.

Journal of cancer research and clinical oncology , vol.147, pp.2721-2729, 2021 (SCI-Expanded)

Trends in the characteristics of skin melanoma in accordance with time intervals: A single Turkish tertiary referral center experience.

Journal of cancer research and therapeutics , vol.17, no.4, pp.1119-1122, 2021 (SCI-Expanded)

Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.

Japanese journal of clinical oncology , vol.51, pp.873-878, 2021 (SCI-Expanded)

Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.

Bayram A., Sari S., Ozluk Y., Tas F., Buyukbabani N.

Journal of cutaneous pathology , vol.48, no.4, pp.472-478, 2021 (SCI-Expanded)

Primary tumour ulceration in cutaneous melanoma: its role on TNM stages.

Japanese journal of clinical oncology , vol.51, pp.192-198, 2021 (SCI-Expanded)

Serum 25-Hydroxyvitamin D Level Is Not Associated with Duration and Activity of Disease in Melanoma Patients

Tas F., Erturk K., Oguz S.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , vol.73, no.7, pp.1126-1129, 2021 (SCI-Expanded) Sustainable Development

Single-agent temozolomide may be an effective option for late adjuvant therapy in patients with melanoma.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.27, no.1, pp.40-45, 2021 (SCI-Expanded)

Paradox in melanoma: more patients fewer publications.

Melanoma research , vol.30, pp.632, 2020 (SCI-Expanded)

Awareness on malignant melanoma and its prevention measures among Turkish cutaneous malignant melanoma patients: A tertiary cancer center experience.

Tas F., Cinar F., Erturk K.

Dermatologic therapy , vol.33, 2020 (SCI-Expanded) Sustainable Development

Google searching as an indicator of population's interest in melanoma: A comparative study in Google Trends.

Dermatologic therapy , vol.33, 2020 (SCI-Expanded)

De Novo and Nevus-Associated Melanomas: Different Histopathologic Characteristics but Similar Survival Rates.

Pathology oncology research : POR , vol.26, pp.2483-2487, 2020 (SCI-Expanded) Sustainable Development

Cutaneous melanoma in vicenarians: Patients in their twenties and older patients show similar clinical behaviors and survival rates

JOURNAL OF COSMETIC DERMATOLOGY , vol.19, pp.2692-2696, 2020 (SCI-Expanded)

SEASONS INFLUENCE DIAGNOSIS AND OUTCOME OF CUTANEOUS MELANOMA.

Dermatologic therapy , vol.33, 2020 (SCI-Expanded) Sustainable Development

BRAF V600E mutation as a prognostic factor in cutaneous melanoma patients.

Dermatologic therapy , vol.33, 2020 (SCI-Expanded)

Spitzoid cutaneous melanoma is associated with favorable clinicopathological factors and outcome.

Journal of cosmetic dermatology , vol.18, pp.1841-1845, 2019 (SCI-Expanded)

Distichiasis in association with entropion in metastatic HER2-positive breast cancer treated by pertuzumab, trastuzumab, and docetaxel combination chemotherapy

Tas F., Ozturker C.

BREAST JOURNAL , 2019 (SCI-Expanded) Sustainable Development

Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma

ANNALS OF PLASTIC SURGERY , vol.83, no.4, pp.455-458, 2019 (SCI-Expanded)

Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?

Erturk K., Karaman S., Dagoglu N., Serilmez M., Duranyildiz D., Tas F.

WIENER KLINISCHE WOCHENSCHRIFT , no.17-18, pp.419-426, 2019 (SCI-Expanded) Sustainable Development

BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.84, no.3, pp.521-526, 2019 (SCI-Expanded)

Clinical and prognostic significance of BRAF V600E mutation in non-metastatic cutaneous melanoma patients.

Neoplasma , vol.66, no.4, pp.631-636, 2019 (SCI-Expanded)

The course of stage III melanoma in accordance with the severity of node involvement

CURRENT MEDICAL RESEARCH AND OPINION , vol.35, no.10, pp.1819-1824, 2019 (SCI-Expanded)

Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.6, pp.721-726, 2019 (SCI-Expanded)

Early and late relapses of cutaneous melanoma patients

POSTGRADUATE MEDICINE , vol.131, no.3, pp.207-211, 2019 (SCI-Expanded)

Relapse patterns in patients with local and regional cutaneous melanoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , vol.21, no.4, pp.412-419, 2019 (SCI-Expanded)

Cheek Cutaneous Melanomas A Review of 98 Cases

ANNALS OF PLASTIC SURGERY , vol.82, no.4, pp.407-410, 2019 (SCI-Expanded)

Prognostic and Predictive Role of Angiogenic Markers in Non- Small Cell Lung Cancer

Keskin S., Kutluk A., Tas F.

Asian Pacific journal of cancer prevention : APJCP , vol.20, pp.733-736, 2019 (SCI-Expanded) Sustainable Development

Palpebral cutaneous melanomas: a review of 17 cases from a tertiary center

INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.58, no.1, pp.75-79, 2019 (SCI-Expanded)

Clinical significance of serum caveolin-1 levels in gastric cancer patients.

Tas F., Karabulut S., Erturk K., Duranyildiz D.

Experimental oncology , vol.40, pp.323-327, 2018 (SCI-Expanded) Sustainable Development

Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer

Afsar C. U., Karabulut M., Karabulut S., Ozal S. T., Cikot M., Serilmez M., et al.

BIOMOLECULES , vol.8, no.4, 2018 (SCI-Expanded) Sustainable Development

Clinical significance of serum leptin level in patients with gastric cancer

Tas F., Karabulut S., Erturk K., Duranyildiz D.

EUROPEAN CYTOKINE NETWORK , vol.29, no.2, pp.52-58, 2018 (SCI-Expanded) Sustainable Development

Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , vol.20, no.5, pp.607-612, 2018 (SCI-Expanded)

Neurotropism as a prognostic factor in cutaneous melanoma patients.

Neoplasma , vol.65, no.2, pp.304-308, 2018 (SCI-Expanded)

Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , vol.70, no.2, pp.236-240, 2018 (SCI-Expanded) Sustainable Development

Digital clubbing as a first clinical presentation of pulmonary metastases in cutaneous melanoma

POSTGRADUATE MEDICINE , vol.130, no.2, pp.278-279, 2018 (SCI-Expanded) Sustainable Development

Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival

PATHOBIOLOGY , vol.85, no.4, pp.227-231, 2018 (SCI-Expanded)

Cutaneous Melanoma in Association With Ichthyosis Vulgaris

Tas F., Erturk K., DEMİRKESEN C., Goktay F.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , vol.39, no.8, pp.630, 2017 (SCI-Expanded)

Scalp melanoma is associated with high mitotic rate and is a poor prognostic factor for recurrence and outcome

MELANOMA RESEARCH , vol.27, no.4, pp.387-390, 2017 (SCI-Expanded)

Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients

Erturk K., Tas F., Serılmez M., Bilgin E., Yasasever V.

Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.1383-1387, 2017 (SCI-Expanded)

Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma

Afsar C. U., Karabulut M., Karabulut S., Alis H., Gonenc M., Dagoglu N., et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY , no.4, pp.196-200, 2017 (SCI-Expanded) Sustainable Development

Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors

MELANOMA RESEARCH , vol.27, no.2, pp.134-139, 2017 (SCI-Expanded)

Clinical Significance of Circulating Serum Cellular Heat Shock Protein 90 (HSP90) Level in Patients with Cutaneous Malignant Melanoma

Tas F., Bilgin E., Erturk K., Duranyıldız D.

Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.599-601, 2017 (SCI-Expanded)

Assessment of Anxiety and Depression Status in Turkish Cutaneous Melanoma Patients

Tas F., Karabulut S., Guveli H., Kurul S., Erturk K., Guveli M., et al.

Asian Pacific journal of cancer prevention : APJCP , vol.18, pp.369-373, 2017 (SCI-Expanded)

Histological lymphovascular invasion is associated with nodal involvement, recurrence, and survival in patients with cutaneous malignant melanoma

INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.56, no.2, pp.166-170, 2017 (SCI-Expanded)

Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients

CANCER INVESTIGATION , vol.35, no.8, pp.501-505, 2017 (SCI-Expanded)

SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut M., Afsar C. U., Karabulut S., Peker K. D., Gemici E., Dagoglu N., et al.

ACTA MEDICA MEDITERRANEA , no.4, pp.613-619, 2017 (SCI-Expanded) Sustainable Development

Presence of histological regression as a prognostic factor in cutaneous melanoma patients.

Melanoma research , vol.26, pp.492-6, 2016 (SCI-Expanded)

Clinical significance of serum claudin-1 levels in melanoma patients

Tas F., Bilgin E., Erturk K., Duranyildiz D.

MELANOMA RESEARCH , vol.26, no.4, pp.377-381, 2016 (SCI-Expanded)

Zosteriform type in-transit metastasis of melanoma

INDIAN JOURNAL OF MEDICAL RESEARCH , vol.143, pp.143, 2016 (SCI-Expanded)

Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy.

Karabulut S., AFSAR C. U., KARABULUT M., ALIS H., Erturk K., Karaman S., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.21, no.4, pp.895-902, 2016 (SCI-Expanded)

Clinical significance of serum caveolin-1 levels in melanoma patients

Tas F., Karabulut S., Yasasever C. T., Duranyildiz D.

INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.55, no.5, pp.558-562, 2016 (SCI-Expanded) Sustainable Development

Same Chemotherapy Regimen Leads to Different Myelotoxicity in Different Malignancies: A Comparison of Chemotherapy-Associated Myelotoxicity in Patients With Advanced Ovarian and Non-Small-Cell Lung Cancer.

Tas F., Yildiz I., Kilic L., Ciftci R., Keskin S., Sen F.

American journal of therapeutics , vol.23, no.3, 2016 (SCI-Expanded) Sustainable Development

Majority of the most-cited articles on cutaneous malignant melanoma are published in non-dermatology/melanoma specialized journals.

Journal of cancer research and therapeutics , vol.12, pp.612-5, 2016 (SCI-Expanded)

Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?

Erturk K., Tastekin D., Gundogdu G., Tas F., Vatansever S.

BIOMEDICINE & PHARMACOTHERAPY , vol.77, pp.27-29, 2016 (SCI-Expanded)

Exacerbation of psoriasis induced by interferon-alpha treatment for melanoma

Tas F., Atsu N.

CUTANEOUS AND OCULAR TOXICOLOGY , vol.35, no.1, pp.83-84, 2016 (SCI-Expanded)

Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer

Tas F., Karabulut S., Serilmez M., KARABULUT M., Duranyildiz D.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.77, no.1, pp.127-131, 2016 (SCI-Expanded) Sustainable Development

CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1-A) AS A POTENTIAL BIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Afsar C. U., Karabulut M., Alis H., Binboga S., Ozkara I. O., et al.

ACTA MEDICA MEDITERRANEA , vol.32, no.4, pp.1035-1040, 2016 (SCI-Expanded) Sustainable Development

Clinical significance of serum protease activated receptor1 levels in patients with lung cancer

Erturk K., Tastekin D., Bilgin E., Tas F., Disci R., Duranyildiz D.

European Review for Medical and Pharmacological Sciences , vol.20, no.2, pp.243-249, 2016 (SCI-Expanded) Sustainable Development

Pankreas Adenokanserli Hastalarda Serum Ekstrasellüler Matriks Proteinlerinin Prognostik ve Prediktif Değerinin Araştırılması

KARABULUT S., KARABULUT M., ALIS H., DAĞOĞLU N., TAMBAŞ M., KAPA S., et al.

Bakırköy Tıp Dergisi , vol.12, no.1, pp.24-32, 2016 (SCI-Expanded)

Plasma homocysteine, folate and vitamin B12 levels in patients with lung cancer.

Tastekın D., Erturk K., Bozbey H. U., Olmuscelık O., Kızıltan H., Tuna S., et al.

Experimental oncology , vol.37, pp.218-22, 2015 (SCI-Expanded) Sustainable Development

Tongue metastasis of melanoma

Tas F., Karabulut S., Yegen G., Onder S., Ciftci R.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.11, no.3, 2015 (SCI-Expanded)

Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.36, no.3, pp.2097-103, 2015 (SCI-Expanded) Sustainable Development

Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICINE & PHARMACOTHERAPY , vol.70, pp.19-23, 2015 (SCI-Expanded) Sustainable Development

D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients.

Kilic L., Yildiz I., Sen F. K., ERDEM M. G., Serilmez M., Keskin S., et al.

Cancer biomarkers : section A of Disease markers , vol.15, no.4, pp.405-11, 2015 (SCI-Expanded) Sustainable Development

Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Biomedicine and Pharmacotherapy , vol.69, pp.237-241, 2015 (SCI-Expanded) Sustainable Development

Combination of Capecitabine and Phenytoin May Cause Phenytoin Intoxication: A Case Report

Ciftci R., Tas F., Karabulut S., CIFTCI S.

AMERICAN JOURNAL OF THERAPEUTICS , vol.22, no.1, 2015 (SCI-Expanded) Sustainable Development

Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer

Tas F., Bilgin E., Karabulut S., Duranyildiz D.

CYTOKINE , vol.71, no.1, pp.66-70, 2015 (SCI-Expanded) Sustainable Development

Clinical significance of serum epithelial cell adhesion molecule (EPCAM) levels in patients with lung cancer

Tas F., Karabulut S., Duranyildiz D.

MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.396, pp.307-312, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum M30 and M65 levels in patients with breast cancer

Tas F., Karabulut S., Yildiz I., Duranyildiz D.

BIOMEDICINE & PHARMACOTHERAPY , vol.68, no.8, pp.1135-1140, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum fibronectin and vitronectin levels in melanoma patients

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

MELANOMA RESEARCH , vol.24, no.5, pp.475-479, 2014 (SCI-Expanded)

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) in patients with breast cancer

Tas F., Karabulut S., Bilgin E., Tastekin D., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.9, pp.9303-9309, 2014 (SCI-Expanded) Sustainable Development

The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY , vol.35, no.9, pp.8849-8860, 2014 (SCI-Expanded) Sustainable Development

The Behavior of Turkish Cancer Patients in Fasting During the Holy Month of Ramadan

Tas F., Karabulut S., Ciftci R., Yildiz I., Keskin S., Kilic L., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.44, no.8, pp.705-710, 2014 (SCI-Expanded) Sustainable Development

Serum levels of vascular cell adhesion molecule-1 (VCAM-1) may have diagnostic, predictive, and prognostic roles in patients with lung cancer treated with platinum-based chemotherapy

Tas F., Karabulut S., Bilgin E., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.8, pp.7871-7875, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum tenascin-c levels in epithelial ovarian cancer

Didem T., Faruk T., Senem K., Derya D., Murat S., Murat G., et al.

TUMOR BIOLOGY , vol.35, no.7, pp.6777-6782, 2014 (SCI-Expanded) Sustainable Development

Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma

Tas F., Karabulut S., Yasasever C., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.7, pp.7233-7237, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum tenascin-C levels in breast cancer

Tastekin D., Tas F., Karabulut S., Duranyildiz D., Serilmez M., Guveli M., et al.

TUMOR BIOLOGY , vol.35, no.7, pp.6619-6625, 2014 (SCI-Expanded) Sustainable Development

Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy

Tas F., Karabulut S., Ciftci R., Sen F., Sakar B., Disci R., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.73, no.6, pp.1163-1171, 2014 (SCI-Expanded) Sustainable Development

Coagulation tests show significant differences in patients with breast cancer

Tas F., Kilic L., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.6, pp.5985-5992, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum ADP-ribosylation and NAD glycohydrolase activity in patients with colorectal cancer.

Varol B., ÇOŞKUN Ö., Karabulut S., SERIN K. R., Asoglu O., Albeniz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.35, no.6, pp.5575-82, 2014 (SCI-Expanded) Sustainable Development

Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

Karabulut S., Aksit E., Tas F., Ciftci R., Aydiner A., Yildiz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.35, no.5, pp.4323-9, 2014 (SCI-Expanded) Sustainable Development

An analysis of the most-cited research papers on oncology: which journals have they been published in?

TUMOR BIOLOGY , vol.35, no.5, pp.4645-4649, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.4, pp.3095-3102, 2014 (SCI-Expanded) Sustainable Development

Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.4, pp.3327-3331, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum transforming growth factor-beta 1 (TGF-beta 1) levels in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.4, pp.3611-3616, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.4, pp.3125-3132, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.

TUMOR BIOLOGY , vol.35, no.3, pp.2729-2739, 2014 (SCI-Expanded)

Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma

Karabulut S., Tas F., Akyuz F., Ormeci A., Serilmez M., Soydinc H. O., et al.

TUMOR BIOLOGY , vol.35, no.3, pp.2327-2333, 2014 (SCI-Expanded) Sustainable Development

Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer

Tas F., Karabulut S., Serilmez M., Ciftci R., Duranyildiz D.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.73, no.3, pp.631-637, 2014 (SCI-Expanded) Sustainable Development

Recurrent gastric cancer presenting with both scrotal and facial skin metastases: a case report.

Tas F., Ciftci R., Buyukbabani N., Karabulut S.

Journal of gastrointestinal cancer , vol.45, pp.96-9, 2014 (SCI-Expanded) Sustainable Development

High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer

Ciftci R., Tas F., Yasasever C., Aksit E., Karabulut S., Sen F., et al.

Tumor Biology , vol.35, no.7, pp.6941-6948, 2014 (SCI-Expanded) Sustainable Development

Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma.

Tas F., Karabulut S., Bilgin E., Kılıc L., Cıftcı R., Duranyıldız D.

Journal of gastrointestinal cancer , vol.44, pp.404-9, 2013 (SCI-Expanded)

Clinical significance of serum M30 and M65 levels in metastatic pancreatic adenocarcinoma

Tas F., Karabulut S., Bilgin E., Sen F., Yildiz I., Tastekin D., et al.

TUMOR BIOLOGY , vol.34, no.6, pp.3529-3536, 2013 (SCI-Expanded)

Age is a prognostic factor affecting survival in lung cancer patients

Tas F., Ciftci R., Kilic L., Karabulut S.

ONCOLOGY LETTERS , vol.6, no.5, pp.1507-1513, 2013 (SCI-Expanded) Sustainable Development

The role of surgical methods in the treatment of anorectal malignant melanoma (AMM).

Keskin S., Tas F., Karabulut S., Yildiz I., Kiliç L., Ciftci R., et al.

Acta chirurgica Belgica , vol.113, pp.429-33, 2013 (SCI-Expanded)

Clinical significance of serum M30 and M65 levels in melanoma

Tas F., Karabulut S., Serilmez M., Yildiz I., Sen F., Ciftci R., et al.

MELANOMA RESEARCH , vol.23, no.5, pp.390-395, 2013 (SCI-Expanded)

Performance status of patients is the major prognostic factor at all stages of pancreatic cancer

Tas F., Sen F., Odabas H., Kilic L., Keskin S., Yildiz I.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.18, no.5, pp.839-846, 2013 (SCI-Expanded) Sustainable Development

Clinical and prognostic significance of coagulation assays in gastric cancer.

Tas F., Ciftci R., Kilic L., Serilmez M., Karabulut S., Duranyildiz D.

Journal of gastrointestinal cancer , vol.44, pp.285-92, 2013 (SCI-Expanded) Sustainable Development

Patellar metastasis of melanoma

INDIAN JOURNAL OF MEDICAL RESEARCH , vol.138, pp.370, 2013 (SCI-Expanded)

A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer

Yildiz I., Tas F., Kilic L., Sen F., Saip P., Eralp Y., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.72, no.2, pp.437-444, 2013 (SCI-Expanded) Sustainable Development

Biweekly triplet chemotherapy with gemcitabine, cisplatin and vinorelbine for advanced chemotherapy naïve non-small cell lung cancer.

Keskin S., Tas F., Ekenel M., Kilic L., Sen F., Yildiz I., et al.

Tumori , vol.99, no.4, pp.463-8, 2013 (SCI-Expanded) Sustainable Development

Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS)

Tas F., Sen F., Keskin S., Kilic L.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , vol.27, no.6, pp.789-792, 2013 (SCI-Expanded) Sustainable Development

Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer

Tas F., Sen F., Guney N., Keskin S., Camlica H.

ONCOLOGY LETTERS , vol.5, no.5, pp.1699-1703, 2013 (SCI-Expanded) Sustainable Development

Clinical and prognostic significance of coagulation assays in lung cancer

Tas F., Kilic L., Serilmez M., Keskin S., Sen F., Duranyildiz D.

RESPIRATORY MEDICINE , vol.107, no.3, pp.451-457, 2013 (SCI-Expanded) Sustainable Development

Clinical and Prognostic Significance of Coagulation Assays in Advanced Epithelial Ovarian Cancer

Tas F., Kilic L., Bilgin E., Keskin S., Sen F., Ciftci R., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.23, no.2, pp.276-281, 2013 (SCI-Expanded) Sustainable Development

Adrenocortical carcinoma: clinicopathological features, prognostic factors and outcome.

Keskin S., Tas F., Vatansever S.

Urologia internationalis , vol.90, no.4, pp.435-8, 2013 (SCI-Expanded)

Clinical and prognostic significance of coagulation assays in melanoma

Tas F., Ciftci R., Kilic L., Bilgin E., Keskin S., Sen F., et al.

MELANOMA RESEARCH , vol.22, no.5, pp.368-375, 2012 (SCI-Expanded) Sustainable Development

Age-specific incidence ratios of colorectal cancer (CRC) in Turkey: CRC in older people is increasing

ARCHIVES OF GERONTOLOGY AND GERIATRICS , vol.55, no.2, pp.279-282, 2012 (SCI-Expanded) Sustainable Development

Association of clinical and pathological variables with survival in thymoma.

Aydiner A., Toker A., Sen F., Bicakci E., Saglam E. K., Erus S., et al.

Medical oncology (Northwood, London, England) , vol.29, no.3, pp.2221-8, 2012 (SCI-Expanded) Sustainable Development

Age-specific incidence ratios of lung cancer (LC) in Turkey: LC in older people is increasing

ARCHIVES OF GERONTOLOGY AND GERIATRICS , vol.55, no.2, pp.276-278, 2012 (SCI-Expanded) Sustainable Development

Age-specific incidence ratios of breast cancer (BC) in Turkey: BC in older people is increasing

ARCHIVES OF GERONTOLOGY AND GERIATRICS , vol.55, no.1, pp.112-115, 2012 (SCI-Expanded) Sustainable Development

The major stressful life events and cancer: stress history and cancer

Tas F., Karalar U., Aliustaoglu M., Keskin S., Can G., Cinar F. E.

MEDICAL ONCOLOGY , vol.29, no.2, pp.1371-1377, 2012 (SCI-Expanded) Sustainable Development

The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia

Aydiner A., Keskin S., Berkman S., Bengisu E., Ilhan H. R., Tas F., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.138, no.6, pp.971-977, 2012 (SCI-Expanded)

Factors Influencing the Hormone Receptor and HER2 Levels in Breast Cancer: A Population-Based Analysis

ONKOLOGIE , vol.35, no.3, pp.95-98, 2012 (SCI-Expanded) Sustainable Development

Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors.

Journal of oncology , vol.2012, pp.647684, 2012 (SCI-Expanded)

Classic Kaposi's sarcoma with colonic involvement: a rare presentation with successful treatment with oral etoposide.

Tas F., Keskın S., Yegen G., Gozubuyukoglu N.

Journal of cancer research and therapeutics , vol.8, pp.112-3, 2012 (SCI-Expanded)

Melanoma-associated hypopigmentation in association with locoregional relapse of melanoma

SURGERY , vol.150, no.5, pp.1011-1012, 2011 (SCI-Expanded)

Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non-Small-Cell Lung Cancer: A Phase II Study

Aydiner A., Sen F., SAGLAM E. K., Oral E. N., Eralp Y., Tas F., et al.

CLINICAL LUNG CANCER , vol.12, no.5, pp.286-292, 2011 (SCI-Expanded) Sustainable Development

Matrix metalloproteinase-9 decreased after chemotherapy in patients with non-small cell lung cancer

Ertan E., Soydinc H., YAZAR A., Ustuner Z., Tas F., Yasasever V.

TUMORI , vol.97, no.3, pp.286-289, 2011 (SCI-Expanded) Sustainable Development

Noncutaneous Melanoma Have Distinct Features from Each Other and Cutaneous Melanoma

Tas F., Keskin S., Karadeniz A., Dagoglu N., Sen F., Kilic L., et al.

ONCOLOGY , no.5-6, pp.353-358, 2011 (SCI-Expanded) Sustainable Development

Age-specific Incidence Ratios in Malignant Melanoma in Turkey: Melanoma in Older People is Increasing

ACTA DERMATO-VENEREOLOGICA , vol.91, no.3, pp.353-354, 2011 (SCI-Expanded) Sustainable Development

Cardiac involvement in melanoma: a case report and review of the literature.

Tas F., Mudun A., KIRMA C.

Journal of cancer research and therapeutics , vol.6, no.3, pp.359-61, 2010 (SCI-Expanded) Sustainable Development

Statistical Interpretation of CA125 and Bcl-2 in Serum of Patients With Late Stage Ovarian Cancer

Camlica H., Duranyildiz D., Tas F., Yasasever V.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.31, no.6, pp.585-588, 2008 (SCI-Expanded) Sustainable Development

Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer.

Topuz E., DERIN D., CAN G., Kuerklue E., Cinar S., Aykan F., et al.

Investigational new drugs , vol.26, no.6, pp.567-72, 2008 (SCI-Expanded) Sustainable Development

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., Topuz E.

MEDICAL ONCOLOGY , vol.25, no.4, pp.431-436, 2008 (SCI-Expanded)

The contribution of countries and world regions in productivity of oncological publication.

Annals of oncology : official journal of the European Society for Medical Oncology , vol.19, no.11, pp.1962-8, 2008 (SCI-Expanded)

Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases

Tas F., Duranyildiz D., Oguz H., Camlica H., Yasasever V., Topuz E.

MEDICAL ONCOLOGY , vol.25, no.3, pp.346-349, 2008 (SCI-Expanded) Sustainable Development

Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer

Tas F., Derin D., Guney N., Aydiner A., Topuz E.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.4, pp.330-334, 2008 (SCI-Expanded) Sustainable Development

Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer

Tas F., Guney N., Derin D., Camlica H., Aydiner A., Topuz E.

INVESTIGATIONAL NEW DRUGS , vol.26, no.4, pp.363-368, 2008 (SCI-Expanded) Sustainable Development

Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer

Aydiner A., Tas F.

TRIALS , vol.9, 2008 (SCI-Expanded) Sustainable Development

Temozolomide in combination with fotemustine in patients with metastatic melanoma

Tas F., Camlica H., Topuz E.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.62, no.2, pp.293-298, 2008 (SCI-Expanded)

Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer

Guney N., Soydinc H. O., Derin D., Tas F., Camlica H., Duranyildiz D., et al.

MEDICAL ONCOLOGY , vol.25, no.2, pp.194-200, 2008 (SCI-Expanded) Sustainable Development

Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer

Tas F., Duranyildiz D., Soydinc H. O., Cicin I., Selam M., Uygun K., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.61, no.5, pp.721-725, 2008 (SCI-Expanded) Sustainable Development

A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer

Tas F., Guney N., Derin D., Aydiner A., Topuz E.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.13, no.2, pp.156-160, 2008 (SCI-Expanded) Sustainable Development

The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy in patients with advanced nonsmall cell lung cancer

Yazar A., SOYDINC H., Ertan E., Yasasever V., Tas F.

SOUTHERN MEDICAL JOURNAL , vol.101, no.3, pp.327-328, 2008 (SCI-Expanded) Sustainable Development

Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer

Derin D., Soydinc H. O., Guney N., Tas F., Camlica H., Duranyildiz D., et al.

LUNG CANCER , vol.59, no.2, pp.240-245, 2008 (SCI-Expanded) Sustainable Development

Macrophage migration inhibitory factor in cancer

Yasasever V., Camlica H., Duranyildiz D., Oguz H., Tas F., Dalay N.

CANCER INVESTIGATION , vol.25, no.8, pp.715-719, 2007 (SCI-Expanded) Sustainable Development

Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma

Tas F., Derin D., Guney N., Camlica H., Aydiner A., Topuz E.

LUNG CANCER , vol.57, no.1, pp.79-83, 2007 (SCI-Expanded) Sustainable Development

Pattern and outcome of admission to a medical oncology inpatient service

Tas F., ARGON A., Disci R., TOPUZ E.

JOURNAL OF CANCER EDUCATION , vol.22, no.2, pp.80-85, 2007 (SCI-Expanded) Sustainable Development

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

Karagol H., Saip P., Uygun K., Caloglu M., Eralp Y., Tas F., et al.

MEDICAL ONCOLOGY , vol.24, no.1, pp.39-43, 2007 (SCI-Expanded) Sustainable Development

Serum IL-8 and IL-12 levels in breast cancer

Derin D., SOYDINC H. O., Güney N., Tas F., Çamlıca H., Duranyıldız D., et al.

MEDICAL ONCOLOGY , vol.24, no.2, pp.163-168, 2007 (SCI-Expanded) Sustainable Development

Malignant melanoma in Turkey: A single institution's experience on 475 cases

Tas F., Kurul S., Camlica H., Topuz E.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.12, pp.794-799, 2006 (SCI-Expanded)

Increased sister chromatid exchange frequency in young women with breast cancer and in their first-degree relatives.

Cefle K., Ucur A., Guney N., Ozturk S., Palanduz S., Tas F., et al.

Cancer genetics and cytogenetics , vol.171, pp.65-7, 2006 (SCI-Expanded) Sustainable Development

Sentinel lymph node biopsy for the staging of anal melanoma: Report of two cases

Şanlı Y., Turkmen C., Kurul S., Tas F., Mudun A., Cantez S.

ANNALS OF NUCLEAR MEDICINE , vol.20, no.9, pp.629-631, 2006 (SCI-Expanded) Sustainable Development

Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients

Tas F., Duranyıldız D., OĞUZ H., Çamlıca H., Yasasever V., Topuz E.

MELANOMA RESEARCH , vol.16, no.5, pp.405-411, 2006 (SCI-Expanded) Sustainable Development

Serum vascular endothelial growth factor (VEGF) and Bcl-2 levels in advanced stage non-small cell lung cancer

Tas F., Duranyıldız D., OĞUZ H., Çamlıca H., Yasasever V., Topuz E.

CANCER INVESTIGATION , vol.24, no.6, pp.576-580, 2006 (SCI-Expanded) Sustainable Development

Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer

Tas F., DURANYILDIZ D., Oguz H., CAMLICA H., YASASEVER V., TOPUZ E.

CANCER INVESTIGATION , vol.24, no.5, pp.492-496, 2006 (SCI-Expanded) Sustainable Development

Penile metastasis of cutaneous malignant melanoma: a true hematogenous spread? Case report and review of the literature

Kurul S., Aykan F., Tas F.

MELANOMA RESEARCH , vol.16, no.3, pp.259-261, 2006 (SCI-Expanded)

Images in pathology. Tumor spreading along an incisional scar line.

Tas F., Yavuz E.

International journal of surgical pathology , vol.14, no.2, pp.143, 2006 (SCI-Expanded)

The value of serum bcl-2 levels in advanced epithelial ovarian cancer.

TAS F., DURANYILDIZ D., OGUZ H., CAMLICA H., Yasasever V., TOPUZ E.

Medical oncology (Northwood, London, England) , vol.23, no.2, pp.213-7, 2006 (SCI-Expanded) Sustainable Development

Intermediate dose interferon alpha in adjuvant treatment for high-risk melanoma - A single institution's experience

Tas F., Kurul S., Camlica H., Topuz E.

MEDICAL ONCOLOGY , vol.23, no.4, pp.471-477, 2006 (SCI-Expanded) Sustainable Development

Serum and urine survivin levels in breast cancer

Güney N., SOYDINE H., DEFIN D., Tas F., Çamlıca H., Duranyıldız D., et al.

MEDICAL ONCOLOGY , vol.23, no.3, pp.335-339, 2006 (SCI-Expanded) Sustainable Development

Temozolomide in combination with cisplatin in patients with metastatic melanoma: a phase II trial.

Tas F., Argon A., Camlica H., Topuz E.

Melanoma research , vol.15, no.6, pp.543-8, 2005 (SCI-Expanded)

Different manifestations of malignant melanoma in the breast: a report of 12 cases and a review of the literature.

Kurul S., Tas F., Buyukbabani N., Mudun A., Baykal C., Camlica H.

Japanese journal of clinical oncology , vol.35, no.4, pp.202-6, 2005 (SCI-Expanded) Sustainable Development

Apoptosis of lymphocytes in peripheral blood of patients with melanoma

TAS F., DURANYILDIZ D., ARGON A., GUZ H., CAMLICA H., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.2, pp.177-181, 2005 (SCI-Expanded) Sustainable Development

Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer

TAS F., DURANYILDIZ D., ARGON A., OGUZ H., CAMLICA H., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.4, pp.353-358, 2005 (SCI-Expanded) Sustainable Development

Oxidative stress in breast cancer.

Tas F., Hansel H., Belce A., Ilvan S., Argon A., Camlica H., et al.

Medical oncology (Northwood, London, England) , vol.22, no.1, pp.11-5, 2005 (SCI-Expanded) Sustainable Development

The value of serum Bcl-2 levels in advanced lung cancer patients

TAS F., DURANYILDIZ D., OGUZ H., CAMLICA H., ORAL E., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.2, pp.139-143, 2005 (SCI-Expanded) Sustainable Development

The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.

TAS F., USTUNER Z., CAN G., ERALP Y., CAMLICA H., BASARAN M., et al.

Acta oncologica (Stockholm, Sweden) , vol.44, no.2, pp.161-7, 2005 (SCI-Expanded) Sustainable Development

The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma

TAS F., OGUZ H., ARGON A., DURANYILDIZ D., CAMLICA H., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.3, pp.241-246, 2005 (SCI-Expanded)

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma

TAS F., DURANYILDIZ D., OGUZ H., DISCI R., KURUL S., Yasasever V., et al.

MEDICAL ONCOLOGY , vol.22, no.1, pp.39-44, 2005 (SCI-Expanded) Sustainable Development

Serum bcl-2 and survivin levels in melanoma

TAS F., DURANYILDIZ D., ARGON A., OGUZ H., CAMLICA H., Yasasever V., et al.

MELANOMA RESEARCH , vol.14, no.6, pp.543-546, 2004 (SCI-Expanded)

Successful palliative treatment of an inoperable giant squamous skin cancer: a case report.

Karadeniz A., Arslan M., Cizmeci O., Tas F.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , vol.9, pp.313-6, 2004 (SCI-Expanded) Sustainable Development

Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanoma.

TAS F., Yasasever V., DURANYILDIZ D., CAMLICA H., USTUNER Z., AYDINER A., et al.

American journal of clinical oncology , vol.27, no.3, pp.225-8, 2004 (SCI-Expanded)

Massive and isolated metastases to spleen of uveal malignant melanoma.

Tas F., Ustuner Z., Buyukbabani N., Tenekeci N., Topuz E.

Retina (Philadelphia, Pa.) , vol.24, no.1, pp.170-2, 2004 (SCI-Expanded)

Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trial.

Tas F., Demir C., Camlica H., Ustuner Z., Topuz E.

Medical oncology (Northwood, London, England) , vol.21, no.3, pp.233-40, 2004 (SCI-Expanded) Sustainable Development

Granulosa cell tumor of the ovary: retrospective analysis of 45 cases.

Uygun K., Aydiner A., Saip P., Basaran M., Tas F., Kocak Z., et al.

American journal of clinical oncology , vol.26, no.5, pp.517-21, 2003 (SCI-Expanded)

Retrovesical soft-tissue metastasis of malignant thymoma: case report.

Tas F., Agan M., Tenekeci N., Topuz E.

American journal of clinical oncology , vol.26, no.4, pp.366-8, 2003 (SCI-Expanded)

Combination chemotherapy with docetaxel and irinotecan in metastatic malignant melanoma.

Tas F., Camlica H., Kurul S., Aydiner A., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)) , vol.15, no.3, pp.132-5, 2003 (SCI-Expanded)

Phlebitis due to irinotecan.

Tas F., Karagol H., Karadeniz A. N., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)) , vol.15, no.3, pp.167, 2003 (SCI-Expanded)

Detection of circulating melanoma cells by a two-marker polymerase chain reaction assay in relation to therapy.

Bitisik O., Camlica H., Duranyildiz D., Tas F., Kurul S., Dalay N.

Journal of biochemistry and molecular biology , vol.36, no.2, pp.173-8, 2003 (SCI-Expanded) Sustainable Development

Efficacy of cisplatin and cyclophosphamide combination for recurrent and metastatic carcinoma of the uterine cervix.

Eralp Y., Saip P., Sakar B., Tas F., Aydiner A., Topuz E.

European journal of gynaecological oncology , vol.24, pp.323-6, 2003 (SCI-Expanded)

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study.

Topuz E., Basaran M., Saip P., Aydiner A., Argon A., Sakar B., et al.

American journal of clinical oncology , vol.25, no.6, pp.619-24, 2002 (SCI-Expanded) Sustainable Development

Anemia in oncology practice: relation to diseases and their therapies.

Tas F., Eralp Y., Basaran M., Sakar B., Alici S., Argon A., et al.

American journal of clinical oncology , vol.25, no.4, pp.371-9, 2002 (SCI-Expanded) Sustainable Development

Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.

Argon A., Aydiner A., Tas F., Saip P., Topuz E.

Gynecologic oncology , vol.85, no.2, pp.362-4, 2002 (SCI-Expanded) Sustainable Development

Prognostic role of nm23 gene expression in patients with ovarian cancer.

Tas F., Tuzlali S., Aydiner A., Saip P., Salihoglu Y., Iplikci A., et al.

American journal of clinical oncology , vol.25, no.2, pp.164-7, 2002 (SCI-Expanded) Sustainable Development

Prognostic significance of melanoma inhibiting activity levels in malignant melanoma.

Meral R., Duranyildiz D., Tas F., Camlica H., Yasasever V., Kurul S., et al.

Melanoma research , vol.11, no.6, pp.627-32, 2001 (SCI-Expanded)

Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP-100): a phase II study.

Basaran M., Bavbek E., Sakar B., Eralp Y., Alici S., Tas F., et al.

American journal of clinical oncology , vol.24, no.6, pp.570-5, 2001 (SCI-Expanded) Sustainable Development

Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.

Tas F., Aykan F., Alici S., Kaytan E., Aydiner A., Topuz E.

American journal of clinical oncology , vol.24, no.6, pp.547-50, 2001 (SCI-Expanded) Sustainable Development

Circulating HER-2/NEU levels in patients with melanoma.

Eralp Y., Aydiner A., Toptani S., Tas F., Camlica H., Topuz E.

CLINICAL CANCER RESEARCH , vol.7, no.11, 2001 (SCI-Expanded)

Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.

Tas F., Aydiner A., Demir C., Topuz E.

American journal of clinical oncology , vol.24, no.4, pp.376-8, 2001 (SCI-Expanded) Sustainable Development

Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation.

Eralp Y., Aydiner A., Tas F., Saip P., Topuz E.

American journal of clinical oncology , vol.24, no.4, pp.347-50, 2001 (SCI-Expanded)

Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.

TAS F., AYKAN F., AYDINER A., Yasasever V., TOPUZ E.

American journal of clinical oncology , vol.24, no.2, pp.148-9, 2001 (SCI-Expanded) Sustainable Development

The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage IC ovarian carcinoma

Topuz E., Eralp Y., Saip P., Aydiner A., Tas F., Salihoglu Y., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.22, no.1, pp.70-73, 2001 (SCI-Expanded) Sustainable Development

Hypertrophic osteoarthropathy associated with docetaxel treatment.

Tas F., Aydiner A., Tenekeci N., Karadeniz A. N., Sakar B., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)) , vol.13, no.2, pp.145-6, 2001 (SCI-Expanded)

The efficacy of combination chemotherapy including intraperitoneal cisplatinum and mitoxantrone with intravenous ifosfamide in patients with FIGO stage I C ovarian carcinoma.

Topuz E., Eralp Y., Saip P., Aydiner A., Taş F., Saliho Y., et al.

European journal of gynaecological oncology , vol.22, pp.70-3, 2001 (SCI-Expanded)

The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.

Topuz E., Eralp Y., Aydiner A., Saip P., Taş F., Yavuz E., et al.

European journal of gynaecological oncology , vol.22, pp.469-72, 2001 (SCI-Expanded)

5-fluorouracil-induced balanitis in a patient with oesophageal carcinoma.

Tas F., Basaran M., Aydiner A., Eralp Y., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)) , vol.13, no.3, pp.170-1, 2001 (SCI-Expanded)

Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.

Tas F., Aydiner A., Topuz E., YASASEVER V., Karadeniz A. N., Saip P. M.

Journal of experimental & clinical cancer research : CR , vol.19, no.4, pp.477-81, 2000 (SCI-Expanded) Sustainable Development

Angiogenesis and p53 protein expression in breast cancer - Prognostic roles and interrelationships

TAS F., Yavuz E., AYDINER A., SAİP P., DISCI R., IPLIKCI A., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.23, no.6, pp.546-553, 2000 (SCI-Expanded) Sustainable Development

Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.

Aydiner A., Karadeniz A. N., Uygun K., Tas S., Tas F., Disci R., et al.

American journal of clinical oncology , vol.23, no.4, pp.364-70, 2000 (SCI-Expanded) Sustainable Development

Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.

Topuz E., Salihoglu Y., Aydiner A., Saip P., Tas F., Sozen T., et al.

Journal of surgical oncology , vol.74, pp.223-6, 2000 (SCI-Expanded) Sustainable Development

Celsite (R) port and catheter as an intraperitoneal access device in the treatment of ovarian cancer

TOPUZ E., Salihoglu Y., AYDINER A., Saip P. M., TAS F., SOZEN T., et al.

JOURNAL OF SURGICAL ONCOLOGY , vol.74, no.3, pp.223-226, 2000 (SCI-Expanded) Sustainable Development

Serum levels of the soluble adhesion molecules in patients with malignant melanoma

YASASEVER F. V., TAŞ F., DURANYILDIZ H. D., Çamlıca H., KURUL S., DALAY M. N.

PATHOLOGY & ONCOLOGY RESEARCH , vol.6, no.1, pp.42-45, 2000 (SCI-Expanded)

The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival.

Tas F., Aykan N., Aydiner A., Uygun K., Basaran M., Camlica H., et al.

American journal of clinical oncology , vol.23, no.1, pp.53-7, 2000 (SCI-Expanded) Sustainable Development

The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.

TOPUZ E., ERALP Y., AYDINER A., Saip P. M., TAS F., YAVUZ E., et al.

ANNALS OF ONCOLOGY , vol.11, pp.87-88, 2000 (SCI-Expanded)

Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day.

Aydiner A., Koyuncu H., Tas F., Topuz E., Disci R.

International journal of clinical pharmacology research , vol.20, pp.21-30, 2000 (SCI-Expanded)

Chemotherapy in advanced breast carcinoma: Efficacy of primary and secondary or tertiary docetaxel use.

Aydiner A., Topuz E., Argon A., Saip P., Tas F., Eralp Y., et al.

ANNALS OF ONCOLOGY , vol.11, pp.37, 2000 (SCI-Expanded)

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.

TOPUZ E., AYDINER A., Saip P. M., ERALP Y., TAS F., Salihoglu Y., et al.

European journal of gynaecological oncology , vol.21, no.6, pp.599-602, 2000 (SCI-Expanded) Sustainable Development

Long term results and prognostic factors of granulosa cell tumors of the ovary.

SAİP P. M., Uygun K., Topuz E., BAŞARAN M., TAŞ F., AYDINER A., et al.

ANNALS OF ONCOLOGY , vol.11, pp.87, 2000 (SCI-Expanded)

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil and calcium folinate in stage II-III gastric cancer

Topuz E., Aykan F., Basaran M., Uygun K., Tas F., Sakar B., et al.

EUROPEAN JOURNAL OF CANCER , vol.35, 1999 (SCI-Expanded) Sustainable Development

Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer.

Tas F., Aydiner A., Topuz E., Camlica H., Saip P., Eralp Y.

Acta oncologica (Stockholm, Sweden) , vol.38, no.8, pp.1011-5, 1999 (SCI-Expanded) Sustainable Development

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology Group.

Icli F., Celik I., Aykan F., Uner A., Demirkazik A., Ozet A., et al.

Cancer , vol.83, no.12, pp.2475-80, 1998 (SCI-Expanded)

Clinical efficacy of diazepam in prophylaxis of acute and delayed emesis induced by cisplatin based chemotherapy. A prospective randomised trial

Saip P., Onat H., Basaran M., Tas F., Demir C., Uygun K., et al.

ANNALS OF ONCOLOGY , vol.9, pp.146, 1998 (SCI-Expanded)

ECG and blood pressure changes during the 6-hours paclitaxel infusion

Saip P., Basaran M., Aydimer A., Erdogan O., Salepci T., Tas F., et al.

EUROPEAN JOURNAL OF CANCER , vol.33, pp.247, 1997 (SCI-Expanded)

Oral etoposide in patients (pts) with Kaposi's sarcoma (KS)

Aydiner A., Tas F., Saip P., Karadeniz A., Demir C., Salepci T., et al.

EUROPEAN JOURNAL OF CANCER , vol.33, pp.1178, 1997 (SCI-Expanded)

Oral etoposide in patients with small cell lung cancer

Topuz E., Tas F., Aydiner A., Demir C., Saip P., Salepci T., et al.

EUROPEAN JOURNAL OF CANCER , vol.33, pp.1072, 1997 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals

A Modified H-index Calculated Using the Duration of Professional Experience and the Author's Significant Contribution to Publications.

TAŞ F., KIZILDAĞ YIRGIN İ.

Cureus , vol.16, no.1, 2024 (ESCI)

Intraabdominal splenosis due to traffic accident

TRAUMA-ENGLAND , no.3, pp.275-276, 2023 (ESCI) Sustainable Development

Widespread finger skin metastases of melanoma

CLINICAL CASE REPORTS , vol.6, no.2, pp.448-449, 2018 (ESCI)

Significance of serum neural precursor cell-expressed developmentally downregulated protein 9 in melanoma

Erturk K., Tas F., Serılmez M., Bilgin E., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , vol.8, no.1, pp.204-208, 2018 (ESCI)

Significant Neutrophilic Emperipolesis in Squamous Cell Carcinoma

Tetikkurt S., Tas F., Emre F., Ozsoy S., Bilece Z. T.

CASE REPORTS IN ONCOLOGICAL MEDICINE , 2018 (ESCI) Sustainable Development

Effect of biology on the outcome of female melanoma patients

Erturk K., Tas F.

MOLECULAR AND CLINICAL ONCOLOGY , vol.7, no.6, pp.1093-1100, 2017 (ESCI)

Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma

MOLECULAR AND CLINICAL ONCOLOGY , vol.7, no.6, pp.1142-1146, 2017 (ESCI) Sustainable Development

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

MOLECULAR AND CLINICAL ONCOLOGY , vol.7, no.6, pp.1083-1088, 2017 (ESCI)

Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma

Karabulut S., Afsar C. U., Karabulut M., Alis H., Bozkurt M. A., Aydogan F., et al.

BBA CLINICAL , vol.6, pp.138-142, 2016 (ESCI) Sustainable Development

Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer

Ciftci R., Taş F., Bilgin E., Keskin S., Yildiz I., Duranyildiz D., et al.

Journal of Oncological Science , vol.2, no.1, pp.7-11, 2016 (Peer-Reviewed Journal) Sustainable Development

Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients

Tas F., Bılgın E., Karabulut S., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , vol.5, no.1, pp.195-200, 2016 (ESCI)

Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients.

Tas F., Bilgin E., Tastekın D., Erturk K., Duranyıldız D.

Journal of gastrointestinal cancer , vol.47, pp.182-6, 2016 (Scopus) Sustainable Development

Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanoma

Tas F., Bilgin E., Karabulut S., Erturk K., Duranyildiz D.

BBA CLINICAL , vol.5, pp.166-169, 2016 (ESCI) Sustainable Development

Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , vol.4, no.5, pp.609-614, 2016 (ESCI) Sustainable Development

Pankreas Adenokanserli Hastalarda Serum Transforme Edici Büyüme Faktör Beta-1 (TGF B1) Düzeyleri

KARABULUT S., KARABULUT M., USUL AFŞAR Ç., ALIŞ H., DAĞOĞLU SAKİN R. N., AKARSU C., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.12, no.1, pp.24-32, 2016 (Peer-Reviewed Journal)

Clinical significance of serum laminin levels in patients with lung cancer

Tas F., Bilgin E., Tastekin D., Erturk K., Duranyildiz D.

BIOMEDICAL REPORTS , vol.4, no.4, pp.485-488, 2016 (ESCI) Sustainable Development

Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome

Tas F., Bılgın E., Karabulut S., Tastekın D., Duranyıldız D.

MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4, pp.655-659, 2016 (ESCI) Sustainable Development

Clinical significance of serum protease-activated receptor-1 levels in gastric cancer patients

Tas F., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICAL REPORTS , vol.4, no.4, pp.489-492, 2016 (ESCI) Sustainable Development

Pankreas adenokarsinomlu hastalarda serum transforme edici büyüme factor beta 1 TGF B1 düzeyleri

KARABULUT S., KARABULUT M., AFŞAR USUL Ç., ALIŞ H., DAĞOĞLU N., AKARSU C., et al.

İstanbul Tıp Fakültesi Dergisi , vol.79, no.1, pp.9-15, 2016 (Peer-Reviewed Journal)

SERUM TRANSFORMING GROWTH FACTOR BETA 1 (TGF-B1) LEVELS IN PANCREATIC ADENOCARCINOMA PATIENTS

Karabulut S., Karabulut M., Usul Afsar C., Alis H., Dagoglu N., Akarsu C., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , no.1, pp.9-15, 2016 (ESCI) Sustainable Development

Pankreas adenokanserli hastalarda serum ekstrasellülermatriks proteinlerininprognostik ve prediktif değerinin araştırılması

KARABULUT S., KARABULUT M., ALIŞ H., DAĞOĞLU R. N., TAMBAŞ M., KAPAN S., et al.

MEDICAL JOURNAL OF BAKIRKOY , vol.12, no.1, pp.24-32, 2016 (Scopus)

The predictive and prognostic value evaluation of serum extracellular matrix proteins levels in patients with pancreas adenocarcinoma

Karabulut S., KARABULUT M., ALIS H., Dagoglu N., Tambas M., KAPAN S., et al.

MEDICAL JOURNAL OF BAKIRKOY , no.1, pp.24-32, 2016 (ESCI) Sustainable Development

Is serum tenascin-C level potential biomarker in pancreatic adenocarcinoma?

Karabulut S., KARABULUT M., ALIS H., Tambas M., KAPAN S., KONES O., et al.

MEDICAL JOURNAL OF BAKIRKOY , vol.12, no.2, pp.76-82, 2016 (ESCI)

CLINICAL SIGNIFICANCE OF CIRCULATING PROINFLAMMATORY CYTOKINE LEVELS IN PATIENTS WITH PANCREATIC ADENOCARCINOMA

Karabulut S., Karabulut M., Afsar C. U., Alis H., Guveli M. E., Unsal M. G., et al.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , vol.78, no.4, pp.102-109, 2015 (ESCI)

Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival.

Tas F., Sen F., Keskin S., Kilic L., Yildiz I.

Molecular and clinical oncology , vol.1, pp.788-792, 2013 (ESCI) Sustainable Development

Mucosal melanoma in the head and neck region: different clinical features and same outcome to cutaneous melanoma.